JP2024513388A5 - - Google Patents

Info

Publication number
JP2024513388A5
JP2024513388A5 JP2023560463A JP2023560463A JP2024513388A5 JP 2024513388 A5 JP2024513388 A5 JP 2024513388A5 JP 2023560463 A JP2023560463 A JP 2023560463A JP 2023560463 A JP2023560463 A JP 2023560463A JP 2024513388 A5 JP2024513388 A5 JP 2024513388A5
Authority
JP
Japan
Prior art keywords
salt
acid
composite particle
compound
core structure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023560463A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024513388A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/022848 external-priority patent/WO2022212717A1/en
Publication of JP2024513388A publication Critical patent/JP2024513388A/ja
Publication of JP2024513388A5 publication Critical patent/JP2024513388A5/ja
Pending legal-status Critical Current

Links

JP2023560463A 2021-03-31 2022-03-31 複合薬物粒子及びその使用 Pending JP2024513388A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163168829P 2021-03-31 2021-03-31
US63/168,829 2021-03-31
PCT/US2022/022848 WO2022212717A1 (en) 2021-03-31 2022-03-31 Composite drug particles and uses thereof

Publications (2)

Publication Number Publication Date
JP2024513388A JP2024513388A (ja) 2024-03-25
JP2024513388A5 true JP2024513388A5 (cg-RX-API-DMAC7.html) 2025-04-08

Family

ID=83456771

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023560463A Pending JP2024513388A (ja) 2021-03-31 2022-03-31 複合薬物粒子及びその使用

Country Status (4)

Country Link
US (1) US20240165130A1 (cg-RX-API-DMAC7.html)
EP (1) EP4312991A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024513388A (cg-RX-API-DMAC7.html)
WO (1) WO2022212717A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102979350B1 (ko) * 2023-03-07 2026-06-18 아주대학교산학협력단 글루코코르티코이드계 화합물을 포함하는 염증의 예방 또는 치료용 약학적 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20011227A1 (es) * 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
GB0009469D0 (en) * 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
JP2007516259A (ja) * 2003-12-09 2007-06-21 メッドクリスタルフォームズ、エルエルシー 活性剤との混合相共結晶の調製方法
MX2013004296A (es) * 2010-10-21 2013-09-26 Cadila Healthcare Ltd Composiciones farmaceuticas topicas que contienen gotas de tamaño nanometrico para el tratamiento de soriasis.
WO2021011753A1 (en) * 2019-07-16 2021-01-21 The Regents Of The University Of Michigan Composite drug particles and uses thereof
CN112915916B (zh) * 2021-01-29 2022-05-24 江南大学 一种pH刺激响应型胆汁盐Pickering复合乳化剂

Similar Documents

Publication Publication Date Title
Gee et al. GABA-dependent modulation of the Cl− ionophore by steroids in rat brain
JP2007535922A5 (cg-RX-API-DMAC7.html)
Katz et al. Topical corticosteroids, structure‐activity and the glucocorticoid receptor: Discovery and development—A process of “planned serendipity”
HRP20161279T1 (hr) Kombinirani preparati s antagonistom citokina i ortikosteroidom
Buchwald et al. Soft glucocorticoid design: structural elements and physicochemical parameters determining receptor-binding affinity
Quinn et al. DHEA in prenatal and postnatal life: implications for brain and behavior
Singh et al. Revisiting the role of steroidal therapeutics in the 21st century: an update on FDA approved steroidal drugs (2000–2024)
Bovenberg et al. Dehydroepiandrosterone administration in humans: evidence based?
Yadav et al. Steroid chemistry and steroid hormone action: a review
DE4339934C2 (de) Ovulationshemmendes Mittel zur hormonalen Kontrazeption
Sitruk-Ware et al. The use of RU 486 as an abortifacient in early pregnancy
Zeelen Medicinal chemistry of steroids
Wang et al. Capillary liquid chromatography combined with tandem mass spectrometry for the study of neurosteroids and oxysterols in brain
US20220257523A1 (en) Composite drug particles and uses thereof
Lutz et al. Allergic contact dermatitis due to topical application of corticosteroids: review and clinical implications
Darley et al. Low dose prednisolone or oestrogen in the treatment of women with late onset or persistent acne vulgaris
Heyns et al. Study of the specificity of the steroid-binding β-globulin in human plasma
US20240165130A1 (en) Composite drug particles and uses thereof
Watanabe et al. Steroid-Induced Thrombosis: Comprehensive Analysis Through Use of the FAERS Database
Hobson Cortisol Based Glucocorticoids
Kirk et al. The structure and nomenclature of steroids
Boettcher et al. Contraceptives in female adolescents with 21-hydroxylase deficiency (CAH)-a way to optimize treatment with respect to androgen excess? A pilot study.
Chen Jr et al. Fluorine-containing steroids
Class et al. Medical uses
OTUKA Study on the Free and Cojugated Steroids in Normal Placenta